Short and Sweet - Recensione dipendente - Controller presso Alluriam

3,0
9 mag 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Healthcare technology investment fund purchasing companies for its investment portfolio

Svantaggi

2 of 3 investment companies left the portfolio during the five months i was there

Esplora altre recensioni su Alluriam